Home › Atopic Dermatitis (Eczema) › New Jersey
Atopic Dermatitis (Eczema) clinical trials in New Jersey
3 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in New Jersey.
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
- Clinical Site 101, Fair Lawn
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Sep 29, 2026 · NCT07453602A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Trail Horizon, Clifton
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813Dupixent and Narrowband UVB for Atopic Dermatitis
- Eczema Treatment Center of New Jersey, East Windsor
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Mar 15, 2024 · NCT05285839From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.